Anti-infectious Drugs in Ophthalmology
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotic Therapy in Infectious Diseases".
Deadline for manuscript submissions: closed (15 October 2022) | Viewed by 7716
Special Issue Editor
Special Issue Information
Dear Colleagues,
The treatment of ocular infections is essential to prevent blindness and to increase the quality of life for patients worldwide. In ophthalmology, anti-microbial agents are unique in terms of their drug formulation, dosage forms, methods of administration, pharmacokinetics and pharmacodynamics, as well as their coverage for microorganism spectra of eye infections. In the recent years, a great number of studies continue to enhance our understanding of the clinical application of ocular antibacterial agents, the epidemiology of antimicrobial-resistances/susceptibility, the development of novel antimicrobials and the investigation of ocular infectious disease. Summarizing and updating the knowledge on antimicrobial agents and their use in diseases with specific clinical characteristics could play a potentially powerful role on the clinical and basic development of ocular infectious disease.
This special issue is dedicated to integrating our current understanding of new developments in the field of ocular anti-infectious agents, including human and veterinary applications of antimicrobial agents, epidemiological data, clinical trials, novel agents/devices and therapeutics, antimicrobial susceptibility testing methods. Manuscripts concerning all basic and clinical research on antimicrobials, antibacterials, antiviral, antifungal, and antiparasitic agents in ophthalmology are welcome.
Prof. Dr. Kaili Wu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobials/ antibactics
- antimicrobial susceptibility
- multi-drug resistance
- antimicrobial device (contact lenses, plugs, sustained-release pellets)
- clinical trials
- epidemiological studies
- ocular pathogenic microbes (bacteria, fungi, virus)
- animal and cell-based models
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.